These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8769477)
1. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Schodin BA; Tsomides TJ; Kranz DM Immunity; 1996 Aug; 5(2):137-46. PubMed ID: 8769477 [TBL] [Abstract][Full Text] [Related]
2. T-cell cytotoxicity assays for studying the functional interaction between the superantigen staphylococcal enterotoxin A and T-cell receptors. Rosendahl A; Kristensson K; Riesbeck K; Dohlsten M Methods Mol Biol; 2000; 145():241-57. PubMed ID: 10820726 [No Abstract] [Full Text] [Related]
3. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343 [TBL] [Abstract][Full Text] [Related]
4. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
5. Quantitative relationship between MHC class II-superantigen complexes and the balance of T cell activation versus death. Lavoie PM; McGrath H; Shoukry NH; Cazenave PA; Sékaly RP; Thibodeau J J Immunol; 2001 Jun; 166(12):7229-37. PubMed ID: 11390471 [TBL] [Abstract][Full Text] [Related]
6. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity. Hornell TM; Myers N; Hansen TH; Connolly JM J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327 [TBL] [Abstract][Full Text] [Related]
7. Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. Andersen PS; Geisler C; Buus S; Mariuzza RA; Karjalainen K J Biol Chem; 2001 Sep; 276(36):33452-7. PubMed ID: 11397806 [TBL] [Abstract][Full Text] [Related]
8. Class I-restricted cytotoxic T cell recognition of split peptide ligands. Gillanders WE; Hanson HL; Rubocki RJ; Hansen TH; Connolly JM Int Immunol; 1997 Jan; 9(1):81-9. PubMed ID: 9043950 [TBL] [Abstract][Full Text] [Related]
9. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480 [TBL] [Abstract][Full Text] [Related]
10. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. Labrecque N; Thibodeau J; Mourad W; Sékaly RP J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467 [TBL] [Abstract][Full Text] [Related]
11. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity. Riquelme E; Carreño LJ; González PA; Kalergis AM Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198 [TBL] [Abstract][Full Text] [Related]
12. Cutting edge: trimolecular interaction of TCR with MHC class II and bacterial superantigen shows a similar affinity to MHC:peptide ligands. Redpath S; Alam SM; Lin CM; O'Rourke AM; Gascoigne NR J Immunol; 1999 Jul; 163(1):6-10. PubMed ID: 10384091 [TBL] [Abstract][Full Text] [Related]
13. Activation of T cells by superantigen in class II-negative mice. Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells. Lee PU; Kranz DM Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280 [TBL] [Abstract][Full Text] [Related]
15. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma. Winter D; Fiebiger E; Meraner P; Auer H; Brna C; Strohal R; Trautinger F; Knobler R; Fischer GF; Stingl G; Maurer D J Immunol; 2003 Sep; 171(5):2714-24. PubMed ID: 12928425 [TBL] [Abstract][Full Text] [Related]
16. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822 [TBL] [Abstract][Full Text] [Related]
17. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells. Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075 [TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. von Bonin A; Ehrlich S; Malcherek G; Fleischer B Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089 [TBL] [Abstract][Full Text] [Related]
19. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008 [TBL] [Abstract][Full Text] [Related]
20. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. Surman S; Deckhut AM; Blackman MA; Woodland DL J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]